Skip to content

Analysis of the curative effect of Qijiao Shengbai capsule on tumor-associated anemia based on real world

Analysis of the curative effect of Qijiao Shengbai capsule on tumor-associated anemia based on real world

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400084273
Enrollment
Unknown
Registered
2024-05-14
Start date
2024-05-14
Completion date
Unknown
Last updated
2024-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ancer related anemia

Interventions

Control group:Not using Qijiaoshengbai Capsules
Treatment group:Using Qijiaoshengbai Capsules

Sponsors

Huzhou Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1: During the case collection period, all patients who met the diagnosis of tumor chemotherapy-related anemia in accordance with the "Expert Consensus on the Diagnosis and Treatment of Anemia Associated with Chemotherapy in China (2019 Edition)" (the diagnostic range of anemia in adult peripheral blood hemoglobin is adult men <120 g/L and adult women <110g/L), and were treated with QiJiao ShengBai Capsule 2: During the case collection period, patients who had the same disease (same main diagnosis) and treatment characteristics as the QiJiao ShengBai Capsule treatment group, but were not treated with QiJiao ShengBai Capsule, were used for data matching analysis with the treatment group.

Exclusion criteria

Exclusion criteria: 1: Anemia caused by bone marrow metastasis or comorbid blood system diseases 2: Patients who have been treated with other Chinese patent medicine with blood-enriching effects 3: Incomplete clinical information.

Design outcomes

Primary

MeasureTime frame
Routine blood test and biochemical indexes;

Secondary

MeasureTime frame
Prognostic analysis indicators;

Countries

CHINA

Contacts

Public ContactChong YAO

Huzhou Central Hospital

hzszxyy@foxmail.com+86 152 6871 5393

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026